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Purpose: The aim of this study was to evaluate and compare the diagnostic performance of 
grayscale ultrasonography (US), US elastography, and US computer-aided diagnosis (US-CAD) in 
the differential diagnosis of breast masses. 
Methods: A total of 193 breast masses in 175 consecutive women (mean age, 46.4 years) from 
June to August 2015 were included. US and elastography images were obtained and recorded. A 
US-CAD system was applied to the grayscale sonograms, which were automatically analyzed and 
visualized in order to generate a final assessment. The final assessments of breast masses were 
based on the American College of Radiology Breast Imaging Reporting and Data System (BI-RADS) 
categories, while elasticity scores were assigned using a 5-point scoring system. The diagnostic 
performance of grayscale US, elastography, and US-CAD was calculated and compared. 
Results: Of the 193 breast masses, 120 (62.2%) were benign and 73 (37.8%) were malignant. 
Breast masses had significantly higher rates of malignancy in BI-RADS categories 4c and 5, 
elastography patterns 4 and 5, and when the US-CAD assessment was possibly malignant (all 
P<0.001). Elastography had higher specificity (40.8%, P=0.042) than grayscale US. US-CAD 
showed the highest specificity (67.5%), positive predictive value (PPV) (61.4%), accuracy (74.1%), 
and area under the curve (AUC) (0.762, all P<0.05) among the three diagnostic tools. 
Conclusion: US-CAD had higher values for specificity, PPV, accuracy, and AUC than grayscale US 
or elastography. Computer-based analysis based on the morphologic features of US may be very 
useful in improving the diagnostic performance of breast US.
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Introduction
In light of the wide application of breast ultrasonography (US) in 
daily practice, the American College of Radiology Breast Imaging 
Reporting and Data System (ACR BI-RADS) for breast US has been 
universally applied to facilitate communication between radiologists 
and clinicians and to standardize the management of women with 
breast abnormalities [1]. Studies have proven the ACR BI-RADS 
lexicon for US to be an effective system in the differential diagnosis 
of breast masses and the detection of malignancies [2-4]. However, 
the US features used in BI-RADS contain an overlap between benign 
and malignant breast masses, particularly in category 4 lesions, as 
this category includes a broad spectrum of breast masses with a 
wide range of risk for malignancy (2%-95%) [5]. At present, no 
specific US descriptor or any combination of US descriptors has been 
reported to accurately predict malignancy in breast masses detected 
on US [6].
With advances in technology, various tools have been developed 
and applied in clinical practice to improve the diagnostic 
performance of breast US. For instance, US elastography, which 
measures and visualizes the intrinsic strain of a target mass, 
providing additional information for mass characterization, has been 
applied to breast US [7-9]. Computer-aided diagnosis (CAD) has 
been applied to breast US interpretation, providing assistance in the 
morphologic analysis of breast masses according to the US BI-RADS 
descriptors as well as final assessments [3,10,11]. These additional 
diagnostic modalities use different characteristics of the target mass 
in lesion assessment; elastography uses tissue stiffness, whereas US-
CAD uses morphologic characteristics. However, to date, no studies 
have compared the diagnostic performance of these additional 
imaging modalities. 
The purpose of this study was to compare the diagnostic 
performance of grayscale US, elastography, and US-CAD in the 
differential diagnosis of breast masses visualized on US. 
Materials and Methods
This retrospective study was approved by the Institutional Review 
Board of (Severance Hospital), and the requirement for informed 
consent was waived. 
Patients 
A total of 193 breast lesions in 175 consecutive women who were 
scheduled for breast US examinations, US-guided biopsy, or surgical 
excision at our institution from June to August 2015 were included 
in this study. The mean age of the 175 women was 46.4 years 
(range, 18 to 81 years). The mean size of the 193 breast masses 
was 14.9 mm (range, 3 to 52 mm). Of these lesions, 180 (93.3%) 
were pathologically diagnosed after US-guided core needle biopsy 
(n=90), vacuum-assisted excision (n=10), or surgical excision (n=80). 
Thirteen lesions (6.5%) were included based on typically benign US 
findings; this category included cysts (n=5) and benign masses that 
had been stable for more than 24 months (n=8). 
US Examinations and Biopsies 
US examinations were performed using a 3-12-MHz linear 
transducer (RS80A with Prestige, Samsung Medison, Co. Ltd., 
Seoul, Korea). Two staff radiologists (J.H.Y and E.-K.K) with 7 
and 19 years of experience in breast imaging, respectively, were 
involved in image acquisition. The clinical information of the patient, 
including mammographic findings and prior US examinations, 
was given to the radiologists before the US examination. Bilateral 
breast examinations were routinely performed, during which the 
target breast masses were detected. Biopsies were performed 
of all breast masses classified as BI-RADS category 4 and 5. In 
addition, 23 masses classified as category 3 were pathologically 
confirmed on the patient’s request. For image analysis using US-
CAD, a single directional movement covering the entire mass with 
surrounding breast parenchyma was recorded as a video clip. The 
elastography and US-CAD systems were applied after grayscale US 
by the same radiologist who performed the US examinations, and 
the elasticity score [7] and final assessment of the US-CAD analysis 
were recorded. The final assessments of grayscale US alone, US 
after incorporating elastography, and US-CAD were also recorded 
according to the ACR BI-RADS categories [1]. If required, a US-
guided biopsy was performed by the radiologist who had initially 
performed breast US after image acquisition.
US Elastography 
US elastography examinations were performed using the freehand 
technique with the transducer placed perpendicular to the skin very 
softly. The US unit showed the images in a split-screen mode with 
grayscale images on the left and the corresponding elastography 
images on the right. For image acquisition, the breast mass was 
centered in the elastography box, in which the superior margin was 
set to cover the subcutaneous fat, the inferior margin to cover the 
pectoralis muscle, and the lateral margins to include a minimum of 5 
mm of normal parenchyma neighboring the breast mass [12]. Real-
time elastography images were acquired as a 256-color mapping 
that showed the amount of strain, using a scale ranging from red 
(largest strain or softest area) to green to blue (no strain or hardest 
area) [13]. 
The elasticity score of each breast mass was prospectively 
evaluated during examination according to the 5-point scale 
Elastography vs. computer-aided diagnosis
e-ultrasonography.org Ultrasonography 36(2), April 2017 155
proposed by Itoh et al. [7]. A score of 1 meant even strain within 
the entire mass, a score of 2 meant even strain throughout the mass 
with some strain-free areas (a mosaic pattern of green and blue), a 
score of 3 meant strain only in the periphery of the mass but not in 
the center, a score of 4 meant no strain within the entire mass, and 
a score of 5 meant no strain within the entire lesion and the normal 
parenchyma surrounding it. 
Application of US-CAD
In order to analyze the US-CAD data for each breast mass, one 
radiologist (J.H.Y) retrospectively reviewed the video clips recorded 
for each breast mass. Representative images were chosen from the 
clips, and a region of interest (ROI) was automatically drawn by the 
S-detect CAD system (RS80A with Prestige, Samsung Medison, Co. 
Ltd.). If the automatically generated ROI was considered inaccurate 
by the radiologist, it was adjusted manually. US characteristics 
according to the BI-RADS lexicon were automatically analyzed and 
visualized by the program, as well as final assessments (Fig. 1). 
The final assessments from US-CAD fell into the two categories of 
probably benign and possibly malignant.
Data and Statistical Analysis
Histopathologic results from US-guided core needle biopsies, 
vacuum-assisted excisions, or surgery were regarded as the standard 
reference. Patients with high-risk lesions on biopsy, including atypical 
ductal hyperplasia, atypical lobular hyperplasia, lobular carcinoma 
in situ, intraductal papilloma, a mucocele-like lesion, or a radial scar, 
were recommended to undergo surgical excision, based on which 
the final pathologic diagnosis was made. These pathologic results 
were regarded as benign for the purposes of statistical analysis. 
For the comparison of continuous variables, the independent two-
sample t test was used. The chi-square test or the Fisher exact test 
was used in the comparison of categorical variables. 
The final assessments based on the US BI-RADS categories 
were divided into two groups for statistical analysis: negative, 
made up of category 2 and 3 lesions, and positive, made up of 
category 4a to 5 lesions. Elasticity scores above 3 were considered 
positive in accordance with the previous study of Itoh et al. [7]. 
The final assessment by US-CAD was also in a dichotomized 
form: negative (probably benign) or positive (possibly malignant). 
Parameters reflecting the diagnostic performance of grayscale US, 
the elasticity score, and US-CAD, including sensitivity, specificity, 
positive predictive value (PPV), negative predictive value (NPV), 
and accuracy, were calculated and compared using the generalized 
estimating equations method. The area under the receiver operating 
characteristics curve (AUC) was acquired and compared using the 
Delong method. 
Statistical analyses were performed using SAS ver. 9.2 (SAS Inc., 
Cary, NC, USA). All tests were two-sided, and P-values of <0.05 
were considered to indicate statistical significance. 
Results
Of the 193 breast masses, 120 (62.2%) were benign and 73 
(37.8%) were malignant. The histopathologic results of the 193 
breast masses are summarized in Table 1. Malignant masses 
were significantly larger than benign masses (19.7±11.5 mm vs. 
11.8±7.0 mm, P<0.001). Women diagnosed with malignant masses 
were significantly older than women with benign masses (51.7±11.6 
years vs. 42.2±12.7 years, P<0.001). 
Fig. 1. The procedure for determining 
the ROI for US-CAD analysis. After the 
ROI was drawn along the border of the 
mass, its ultrasonographic features were 
analyzed automatically by US-CAD and 
a final assessment was produced. ROI, 
region of interest; US, ultrasonography; 
CAD, computer-aided diagnosis.
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4 and 5, and when the US-CAD assessment was possibly malignant 
(all P<0.001).
Table 3 the summarizes the 193 breast masses according to 
pathology and imaging features, including US, elastography, and 
US-CAD. Among the 120 benign breast masses, negative elasticity 
scores were less common than positive elasticity scores (49 [40.8%] 
Distribution of Breast Masses according to US, Elastography, 
and US-CAD
Table 2 summarizes the categories of the 193 breast masses 
according to grayscale US BI-RADS assessment, elastography 
patterns, and US-CAD. Breast masses had significantly higher rates 
of malignancy in BI-RADS categories 4c and 5, elastography patterns 
Table 3. Categorical assessments of the 193 breast masses according to pathology findings and imaging features 
US
Pathology
Benign (n=120) Malignant (n=73) Benign (n=120) Malignant (n=73)
E (-) E (+) P-value E (-) E (+) P-value US-CAD (-) US-CAD (+) P-value US-CAD (-) US-CAD (+) P-value
2 7 (14.3) 3 (4.2) 0.205 0 ( 0 ( 0.592 8 (9.9) 2 (5.1) 0.564 0 ( 0 ( 0.013
3 13 (26.5) 13 (18.3) 0 ( 0 ( 19 (23.5) 7 (17.9) 0 ( 0 (
4a 26 (53.1) 48 (67.6) 4 (28.6) 11 (18.6) 48 (59.3) 26 (66.7) 4 (36.4) 11 (17.7)
4b 2 (4.1) 5 (7.0) 0 ( 4 (6.8) 5 (6.2) 2 (5.1) 2 (18.2) 2 (3.2)
4c 1 (2.0) 2 (2.8) 4 (28.6) 13 (22.0) 1 (1.2) 2 (5.1) 4 (36.4) 13 (21.0)
5 0 ( 0 ( 6 (42.9) 31 (52.5) 0 ( 0 ( 1 (9.1) 36 (58.1)
Total 49 ( 71 ( 14 ( 59 ( 81 ( 39 ( 11 ( 62 (
Values are presented as number (%).
US, ultrasonography; E, elastography; E (-), elastography patterns 1-3; E (+), elastography patterns 4-5; CAD, computer-aided design; US-CAD (-), possibly benign; US-CAD (+), 
possibly malignant.
Table 2. Categorical assessments of the 193 breast masses 
according to US, elastography, and US-CAD
Benign (n=120) Malignant (n=73)
US
Category
2 10 (8.3) 0 (
3 26 (21.7) 0 (
4a 74 (61.7) 15 (20.5)
4b 7 (5.8) 4 (5.5)
4c 3 (2.5) 17 (23.3)
5 0 ( 37 (50.7)
Elastography
Pattern
1 9 (7.5) 0 (
2 40 (33.3) 14 (19.2)
3 42 (35.0) 17 (23.3)
4 22 (18.3) 25 (34.2)
5 7 (5.8) 17 (23.3)
US-CAD
Assessment
Possibly benign 81 (67.5) 11 (15.1)
Possibly malignant 39 (32.5) 62 (84.9)
Values are presented as number (%).
US, ultrasonography; CAD, computer-aided diagnosis.
Table 1. Histopathology results of the 193 breast masses
Histopathology result No. (%)
Benign (n=120) Fibroadenoma or fibroadenomatoid 
hyperplasia 
63 (52.5)
Intraductal papilloma 8 (6.7)
Sclerosing adenosis 7 (5.8)
Radial scar 5 (4.2)
Fibroepithelial tumor 2 (1.7)
Apocrine metaplasia 6 (5) 
Fibrocystic changes 3 (2.5)
Fat necrosis 3 (2.5)
Stromal fibrosis 3 (2.5)
Duct ectasia 3 (2.5)
Granuloma 3 (2.5)
Mucocele-like lesion 1 (0.8)
Typically benigna) 13 (10.8)
Malignant (n=73) Invasive ductal carcinoma 56 (76.7)
Ductal carcinoma in situ 7 (9.6)
Tubular carcinoma 4 (5.5)
Mucinous carcinoma 3 (4.1)
Invasive lobular carcinoma 2 (2.7)
Medullary carcinoma 1 (1.4)
a)The category of typically benign includes ultrasonographic findings such as cysts 
(n=5) or benign masses that have been stable for more than 24 months (n=8).
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vs. 71 [59.2%], P=0.205). Negative US-CAD assessments were 
more common than positive US-CAD assessments in benign breast 
masses, although this trend did not reach statistical significance (81 
[67.5%] vs. 39 [32.5%], P=0.564). Among the 84 benign masses 
assessed as category 4a or higher on grayscale US, more negative 
US-CAD assessments were found than negative elastography scores, 
although this trend was not statistically significant (65.5% [55 of 
84] vs. 34.5% [29 of 84], P=0.864). 
Among the 73 malignant breast masses, positive elasticity scores 
were more common than negative scores (59 [80.8%] vs. 14 
[19.2%], P=0.592). Positive US-CAD assessments were significantly 
more common in malignant breast masses than negative US-CAD 
assessments (62 [84.9%] vs. 11 [15.1%], P=0.013). 
Diagnostic Performance of US, Elastography, and US-CAD
The diagnostic performance of grayscale US, elastography, and US-
CAD is summarized in Table 4. For grayscale US, the sensitivity 
was 100.0%, the specificity was 30.0%, the PPV was 46.5%, the 
NPV was 100.0%, and the accuracy was 56.5%. Elastography 
had significantly lower sensitivity (80.8%) and NPV (77.8%, all 
P<0.001), and higher specificity (40.8%, P=0.042) than grayscale 
US. US-CAD had significantly higher specificity (67.5%), PPV 
(61.4%), and accuracy (74.1%) than grayscale US, with lower 
sensitivity (84.9%) and NPV (88.0%, all P<0.001). In comparison 
with elastography, US-CAD showed better diagnostic performance 
in regard to all parameters (all P<0.001). The AUC was highest for 
US-CAD (0.762), and this value was significantly higher than that of 
grayscale US (0.650, P=0.002) and elastography (0.608, P<0.001) 
(Fig. 2). 
Discussion
Various imaging methods have emerged that provide additional 
information in differentiating breast masses seen on grayscale 
US, such as elastography and US-CAD. These adjunctive imaging 
tools analyze different characteristics of breast masses. Whereas 
elastography measures the intrinsic stiffness of the targeted tissue, 
US-CAD analyzes the morphologic characteristics of a targeted 
breast mass. This is the first study to compare the diagnostic 
performance of these breast US imaging tools that are based on 
different principles, since most earlier studies have focused on the 
individual or combined performance of elastography or US-CAD in 
comparison to US [14-19]. 
Malignant breast masses had significantly higher rates of 
Table 4. Diagnostic performance of grayscale US, elastography, and US-CAD 
US E P-valuea) US-CAD P-valuea) P-valueb)
Sensitivity 73/73 (100.0) 59/73 (80.8) <0.001 62/73 (84.9 ) <0.001 0.531
Specificity 36/120 (30.0) 49/120 (40.8) 0.042 81/120 (67.5) <0.001 <0.001
PPV 73/157 (46.5) 59/130 (45.4) 0.651 62/101 (61.4) <0.001 <0.001
NPV 36/36 (100) 49/63 (77.8) <0.001 81/92 (88.0) <0.001 0.071
Accuracy 109/193 (56.5) 108/193 (56.0) >0.999 143/193 (74.1) <0.001 <0.001
AUC (95% CI) 0.650 (0.609-0.691) 0.608 (0.545-0.672) 0.247 0.762 (0.703-0.821) 0.002 <0.001
Values are presented as number (%) unless otherwise indicated.
US, ultrasonography; CAD, computer-aided diagnosis; E, elastography; PPV, positive predictive value; NPV, negative predictive value; AUC, area under the receiver operating 
characteristics curve; CI, confidence interval.
a)Value compared to grayscale US. b)Value compared to elastography.
Fig. 2. ROC curve for US, elastography, and US-CAD. The solid 
line, dashed line, and dotted line indicate the area under the 
ROC curve for US (0.650), elastography (0.608), and US-CAD 
(0.762), respectively. ROC, receiver operating characteristic; US, 
ultrasonography; CAD, computer-aided diagnosis.
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elastography patterns 4 and 5, as well as US-CAD assessments of 
possibly malignant (all P<0.001) (Table 2). Among the 120 benign 
breast masses, while 36 masses (30.0%) were classified as BI-RADS 
category 2 or 3, 49 masses (40.8%) had negative elasticity scores 
and 81 masses (67.5%) were assessed as probably benign on US-
CAD. In addition, among the 74 benign breast masses (61.7%) 
classified as BI-RADS category 4a, 26 (35.1%) showed negative 
results on elastography and 48 (64.9%) were negative on US-
CAD (Table 3). Based on our results, by applying elastography and 
US-CAD to breast US, we may be able to confidently improve the 
specificity of the diagnosis of breast masses, consistent with earlier 
studies showing that elastography was able to reduce the number 
of benign biopsies of category 4a lesions [14,20,21]. 
Elastography showed a higher specificity (40.8%, P=0.042) than 
grayscale US, although it had significantly lower sensitivity (80.8%) 
and NPV (77.8%, all P<0.001). These results are in agreement with 
those of earlier studies [22-24]. Some studies have evaluated the 
performance of US-CAD using US BI-RADS features when applied 
to biopsy-proven breast masses, showing a high AUC of at least 
0.7 [18,25]. Another recent study reported that US-CAD had higher 
specificity than breast US in the differential diagnosis of breast 
masses [26]. US-CAD showed higher specificity (67.5%), PPV 
(61.4%), and accuracy (74.1%) than grayscale US or elastography 
(all P<0.001), consistent with prior reports. US-CAD analyzes the 
morphologic features of breast masses seen on US, and has been 
shown to exhibit better diagnostic performance than grayscale US 
performed by radiologists or US elastography of the breast. That 
is, the computer-based analysis of US features displayed superior 
performance in comparison to real-time US or the analysis of the 
intrinsic characteristics of breast masses. Analyzing the US features 
alone may have been the cause for the higher performance of US-
CAD, since the radiologists who performed real-time US were 
not blinded to the patients’ clinical conditions or mammographic 
findings. Suspicious US features identified using the ACR BI-RADS 
criteria have very high PPVs [1,5]; therefore, analyzing breast 
masses by strictly considering only their US features may improve 
diagnostic performance. Moreover, as reported in other studies 
using elastography [22,24,27], information regarding the intrinsic 
stiffness of a mass has limitations in providing an accurate diagnosis 
when used in isolation, and such information should be used in 
conjunction with the morphologic features seen on US. 
This study has some limitations. First, all evaluations were done 
by two radiologists, and variability between the operators was 
not considered. Operator dependency of elastography as well 
as grayscale US has been reported for image acquisition and 
interpretation [12,28], and this may have affected our results. 
Second, although a heterogeneous group of breast masses with 
various pathologic diagnoses was included in this study, we 
classified them according to the diagnostic assessment of benign 
or malignant, without comparing the intrinsic features of each 
pathology. Different levels of strain have been noted among 
different pathologic entities [29,30], and this may have affected our 
results. Third, a single radiologist chose representative images and 
confirmed the ROIs in the US-CAD analysis, and it is possible that 
another radiologist would have obtained different results. However, 
the ROIs were manually adjusted only when the automatic ROIs did 
not contain the entire mass contour in some heterogeneous masses. 
In conclusion, US-CAD had higher specificity, PPV, and accuracy 
than grayscale US or elastography. Our results suggest that 
computer-based analysis based on the morphologic features found 
in US imaging may be very useful in improving the diagnostic 
performance of breast US. 
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